149.53MMarket Cap
LossP/E TTM
Nkarta Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Nkarta Inc is 8.53, ranking 87 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.55, which is -66.20% below the recent high of -0.52 and -322.93% above the recent low of -6.55.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.